Inflammatory biomarkers and therapeutic potential of milk exosome-mediated CCL7 siRNA in murine intestinal ischemia-reperfusion injury

BackgroundIntestinal ischemia-reperfusion injury (IIRI) is a severe clinical condition associated with high morbidity and mortality. Despite advances in understanding the pathophysiology of IIRI, effective diagnostic and therapeutic strategies remain limited.MethodsUsing transcriptome sequencing in...

Full description

Saved in:
Bibliographic Details
Main Authors: WenDong Chen, WenPing Xu, Li Ma, Chun Bi, MeiXu Yang, Wei Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1513196/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594099621855232
author WenDong Chen
WenPing Xu
Li Ma
Chun Bi
MeiXu Yang
Wei Yang
author_facet WenDong Chen
WenPing Xu
Li Ma
Chun Bi
MeiXu Yang
Wei Yang
author_sort WenDong Chen
collection DOAJ
description BackgroundIntestinal ischemia-reperfusion injury (IIRI) is a severe clinical condition associated with high morbidity and mortality. Despite advances in understanding the pathophysiology of IIRI, effective diagnostic and therapeutic strategies remain limited.MethodsUsing transcriptome sequencing in a mouse model of IIRI, we identified potential biomarkers that were significantly upregulated in the IIRI group compared to the sham group. Based on these findings, we developed and evaluated a therapeutic strategy using milk-derived exosomes loaded with siRNA targeting CCL7 (M-Exo/siCCL7).ResultsFocusing on Ccl7 as a hub gene, we explored the therapeutic efficacy of milk-derived exosomes loaded with siRNA targeting Ccl7 (M-Exo/siCCL7) in the IIRI model. M-Exo/siCCL7 treatment effectively attenuated intestinal inflammation and injury, as evidenced by reduced histological damage, decreased serum markers of intestinal barrier dysfunction, and attenuated systemic inflammation.ConclusionOur findings provide new insights into the molecular mechanisms underlying IIRI, identify potential diagnostic biomarkers, and highlight the promise of exosome-based siRNA delivery as a novel therapeutic approach for IIRI.
format Article
id doaj-art-c54c06089d834c62823b44b055a84e0a
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-c54c06089d834c62823b44b055a84e0a2025-01-20T05:23:40ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011510.3389/fimmu.2024.15131961513196Inflammatory biomarkers and therapeutic potential of milk exosome-mediated CCL7 siRNA in murine intestinal ischemia-reperfusion injuryWenDong ChenWenPing XuLi MaChun BiMeiXu YangWei YangBackgroundIntestinal ischemia-reperfusion injury (IIRI) is a severe clinical condition associated with high morbidity and mortality. Despite advances in understanding the pathophysiology of IIRI, effective diagnostic and therapeutic strategies remain limited.MethodsUsing transcriptome sequencing in a mouse model of IIRI, we identified potential biomarkers that were significantly upregulated in the IIRI group compared to the sham group. Based on these findings, we developed and evaluated a therapeutic strategy using milk-derived exosomes loaded with siRNA targeting CCL7 (M-Exo/siCCL7).ResultsFocusing on Ccl7 as a hub gene, we explored the therapeutic efficacy of milk-derived exosomes loaded with siRNA targeting Ccl7 (M-Exo/siCCL7) in the IIRI model. M-Exo/siCCL7 treatment effectively attenuated intestinal inflammation and injury, as evidenced by reduced histological damage, decreased serum markers of intestinal barrier dysfunction, and attenuated systemic inflammation.ConclusionOur findings provide new insights into the molecular mechanisms underlying IIRI, identify potential diagnostic biomarkers, and highlight the promise of exosome-based siRNA delivery as a novel therapeutic approach for IIRI.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1513196/fullintestinal ischemia-reperfusion injurybiomarkersinflammationCCL7milk-derived exosomessiRNA delivery
spellingShingle WenDong Chen
WenPing Xu
Li Ma
Chun Bi
MeiXu Yang
Wei Yang
Inflammatory biomarkers and therapeutic potential of milk exosome-mediated CCL7 siRNA in murine intestinal ischemia-reperfusion injury
Frontiers in Immunology
intestinal ischemia-reperfusion injury
biomarkers
inflammation
CCL7
milk-derived exosomes
siRNA delivery
title Inflammatory biomarkers and therapeutic potential of milk exosome-mediated CCL7 siRNA in murine intestinal ischemia-reperfusion injury
title_full Inflammatory biomarkers and therapeutic potential of milk exosome-mediated CCL7 siRNA in murine intestinal ischemia-reperfusion injury
title_fullStr Inflammatory biomarkers and therapeutic potential of milk exosome-mediated CCL7 siRNA in murine intestinal ischemia-reperfusion injury
title_full_unstemmed Inflammatory biomarkers and therapeutic potential of milk exosome-mediated CCL7 siRNA in murine intestinal ischemia-reperfusion injury
title_short Inflammatory biomarkers and therapeutic potential of milk exosome-mediated CCL7 siRNA in murine intestinal ischemia-reperfusion injury
title_sort inflammatory biomarkers and therapeutic potential of milk exosome mediated ccl7 sirna in murine intestinal ischemia reperfusion injury
topic intestinal ischemia-reperfusion injury
biomarkers
inflammation
CCL7
milk-derived exosomes
siRNA delivery
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1513196/full
work_keys_str_mv AT wendongchen inflammatorybiomarkersandtherapeuticpotentialofmilkexosomemediatedccl7sirnainmurineintestinalischemiareperfusioninjury
AT wenpingxu inflammatorybiomarkersandtherapeuticpotentialofmilkexosomemediatedccl7sirnainmurineintestinalischemiareperfusioninjury
AT lima inflammatorybiomarkersandtherapeuticpotentialofmilkexosomemediatedccl7sirnainmurineintestinalischemiareperfusioninjury
AT chunbi inflammatorybiomarkersandtherapeuticpotentialofmilkexosomemediatedccl7sirnainmurineintestinalischemiareperfusioninjury
AT meixuyang inflammatorybiomarkersandtherapeuticpotentialofmilkexosomemediatedccl7sirnainmurineintestinalischemiareperfusioninjury
AT weiyang inflammatorybiomarkersandtherapeuticpotentialofmilkexosomemediatedccl7sirnainmurineintestinalischemiareperfusioninjury